Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure

Journal of Clinical Pharmacology

Volumn 38, Issue 8, 1998, Pages 708-714

  Bleske, Barry E ^a,e   Welage, Lynda S ^a   Kramer, William G ^b,d   Nicklas, John M ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d IQVIA   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TORASEMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG URINE LEVEL; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; SODIUM EXCRETION; URINE VOLUME; VOMITING;

EID: 0031865220     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04810.x     Document Type: Article

References (9)

1. Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC: Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985;102:314-318.
2. Gehr TWB, Rudy DW, Matzke GR, Kramer WG, Sica DA, Brater DC: The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency. Clin Pharmacol Ther 1994;56:31-38.
3. Schwartz S, Brater DC, Pound D, Green PK, Kramer WG, Rudy D: Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis. Clin Pharmacol Ther 1993; 54:90-97.
4. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC: Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with congestive heart failure, Clin Pharmacol Ther 1995;57:601-609.
5. March C, Farthing D, Wells B, Besenfelder E, Karnes HT: Solid phase extraction and liquid chromatography of torsemide and metabolites from plasma and urine. J Pharm Sci 1990;79:453-457.
6. Cavalier R, Pellegrin P, Lesne J, van Ypersele de Strihou CH: Site of action of torsemide in man. Eur J Clin Pharmacol 1986; 31(suppl):15-19.
7. Hammarlund MM, Odlind B, Paalzow KW: Acute tolerance to furosemide diuresis in humans: pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 1985;233:447-453.
8. Li T, Lee MG, Chiou WL: Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide. J Pharmacokinet Biopharm 1986; 14:495-509.
9. Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Friedman PA, Souney PF: Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 1983;102:450-458.